肠道菌群失调介导酒精性肝病发生发展机制的研究进展.PDFVIP

•综 述• 肠道菌群失调介导酒精性肝病发生发展的机制研究进展 ························································· 1 •药物警戒• 欧盟建议采取措施降低含羟嗪药物的心脏疾病风险································································· 6 加拿大限制利培酮适应症············································································································ 7 加拿大警示磺胺甲噁唑甲氧苄啶的药物性免疫性血小板减少风险 ········································· 7 加拿大发布达比加群酯与决奈达隆、胺碘酮药物相互作用的安全性审查结果 ······················ 8 新西兰警示唑来膦酸的肌腱损伤／肌腱炎潜在风险·············································